Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen

This study has been completed.
Information provided by (Responsible Party):
Agennix Identifier:
First received: September 30, 2003
Last updated: August 1, 2012
Last verified: August 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2007
  Primary Completion Date: January 2006 (Final data collection date for primary outcome measure)